Proactive – ImmuPharma “looking forward” to upcoming FDA meetings
27 April 2023
Tim McCarthy, CEO talks to Proactive on recent positive newsflow and his optimism on the forthcoming FDA meetings for Lupuzor for lupus and CIDP – 27 April 2023
